Apollo Therapeutics
- Biotech or pharma, therapeutic R&D
Apollo Therapeutics is a biopharmaceutical company with five clinical stage programs in immunology, cardiometabolic / liver disease and oncology. Three of our drugs are currently in phase 2 trials with two in phase 1 trials. Backed by leading specialist investors including Patient Square Capital and Rock Springs Capital, we have operations in Cambridge, UK, and Boston, USA and have raised over $450 million in financing to date.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}